{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:02:37Z","timestamp":1776776557596,"version":"3.51.2"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Management of BK virus after kidney transplantation remains challenging, as recently published updated guidelines identify ongoing gaps in the evidence. In this article we present tips for management based on evidence and clinical experience. Testing blood for BK virus by polymerase chain reaction should be part of the workup for any patient with significant deterioration in kidney transplant function. All kidney transplant biopsies should be tested by immunohistochemistry for the presence of SV40 large T antigen if there are features of tubulointerstitial inflammation on light microscopy. A transplant kidney biopsy that does not include medulla does not exclude BK virus\u2013associated nephropathy (BKVAN). Tubulointerstitial inflammation with positive SV40 staining and undetectable BK virus in the blood implies a different polyomavirus nephropathy such as JC virus. Clinicians should consider the evidence carefully before deciding whether or not to adopt a BK viraemia screening strategy in their unit. If a strategy of screening for BK viraemia in the absence of transplant dysfunction is adopted, then it makes sense to target the first year and for screening to be at least every 4 weeks. The optimal reduction in immunosuppression in response to BK viraemia or BKVAN has not been established by clinical trials. A rapid decline in BK viral load after reduction in immunosuppression appears to be a strong risk factor for impending T cell\u2013mediated rejection. Clinical trials of the addition of potentially effective anti-polyomavirus agents including leflunomide, fluoroquinolones, intravenous immunoglobulin concentrate, cidofovir and statins have not shown benefit. BK viraemia or BKVAN recurrence after viral clearance is rare.<\/jats:p>","DOI":"10.1093\/ckj\/sfag061","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:36:55Z","timestamp":1771591015000},"source":"Crossref","is-referenced-by-count":0,"title":["Ten tips on management of BK nephropathy in kidney transplant patients"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-6423","authenticated-orcid":false,"given":"Colin C","family":"Geddes","sequence":"first","affiliation":[{"name":"Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital Glasgow , Glasgow ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J","family":"Phelan","sequence":"additional","affiliation":[{"name":"Renal Unit, Royal Infirmary of Edinburgh , Edinburgh ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2026042108113844300_bib1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/TP.0000000000004976","article-title":"The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation","volume":"108","author":"Kotton","year":"2024","journal-title":"Transplantation"},{"key":"2026042108113844300_bib2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/jcla.21978","article-title":"Bright field microscopy to detect decoy dells due to BK virus infection in the fresh and unstained urine sediment in kidney allograft recipients","volume":"30","author":"Poloni","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"2026042108113844300_bib3","article-title":"UK guideline on management of BK polyomavirus (BKPyV) infection and disease following kidney transplantation","author":"British Transplantation Society","year":"2024"},{"key":"2026042108113844300_bib4","first-page":"CD013344","article-title":"Interventions for BK virus infection in kidney transplant recipients","volume":"10","author":"Wajih","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042108113844300_bib5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2215\/CJN.13611119","article-title":"The importance of kidney medullary tissue for the accurate diagnosis of BK virus allograft nephropathy","volume":"29","author":"Nankivell","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026042108113844300_bib6","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.3389\/bjbs.2025.14170","article-title":"JC polyomavirus-associated nephropathy case report: clinical and laboratory learning","volume":"82","author":"Tomb","year":"2025","journal-title":"Br J Biomed Sci"},{"key":"2026042108113844300_bib7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","article-title":"Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation","volume":"84","author":"Drachenberg","year":"2007","journal-title":"Transplantation"},{"key":"2026042108113844300_bib8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/01.tp.0000332620.76865.a6","article-title":"Intensive screening for polyomavirus reactivation and a pre-determined stepwise modification in maintenance immunosuppression therapy: a road map to improve the outcome","volume":"86","author":"Wali","year":"2008","journal-title":"Transplantation"},{"key":"2026042108113844300_bib9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.kint.2024.09.018","article-title":"Insights from the BKEVER trial comparing everolimus versus mycophenolate mofetil for BK polyomavirus infection in kidney transplant recipients","volume":"107","author":"Caillard","year":"2025","journal-title":"Kidney Int"},{"key":"2026042108113844300_bib10","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.ajt.2024.07.002","article-title":"Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1","volume":"24","author":"Abend","year":"2024","journal-title":"Am J Transplant"},{"key":"2026042108113844300_bib11","doi-asserted-by":"publisher","first-page":"e70357","DOI":"10.1002\/jmv.70357","article-title":"A phase I study evaluating safety and tolerability of viral-specific T cells against BK-virus in adult kidney transplant recipients","volume":"97","author":"Ptak","year":"2025","journal-title":"J Med Virol"},{"key":"2026042108113844300_bib12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1681\/ASN.0000000000000329","article-title":"Posoleucel in kidney transplant recipients with BK viremia: multicenter, randomized, double-blind, placebo-controlled phase 2 trial","volume":"35","author":"Chandraker","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026042108113844300_bib13","doi-asserted-by":"publisher","first-page":"102288","DOI":"10.1016\/j.trim.2025.102288","article-title":"Effects of intravenous immunoglobulin (IVIG) treatment on BK viremia and BK virus-associated nephropathy (BKVN) in kidney transplant patients: a systematic review","volume":"93","author":"Hassanian","year":"2025","journal-title":"Transplant Immunol"},{"key":"2026042108113844300_bib14","doi-asserted-by":"publisher","first-page":"105430","DOI":"10.1016\/j.ebiom.2024.105430","article-title":"Composition of the neutralising antibody response predicts risk of BK virus DNAaemia in recipients of kidney transplants","volume":"110","author":"Chong","year":"2024","journal-title":"eBioMedicine"},{"key":"2026042108113844300_bib15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12985-024-02620-7","article-title":"BK polyomavirus and acute kidney injury in transplant recipients: signaling pathways and molecular mechanisms","volume":"22","author":"Bizhani","year":"2025","journal-title":"Virol J"},{"key":"2026042108113844300_bib16","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1038\/s41598-025-93503-6","article-title":"The impact of gamma interferon on BK virus candidate microRNAs and related miRNAs in kidney transplant patients with BK infection","volume":"15","author":"Changizi","year":"2025","journal-title":"Sci Rep"},{"key":"2026042108113844300_bib17","doi-asserted-by":"publisher","first-page":"e15113","DOI":"10.1111\/ctr.15113","article-title":"High grade urothelial carcinoma in kidney transplant patients with a history of BK viremia\u2014just a coincidence?","volume":"37","author":"Cannon","year":"2023","journal-title":"Clin Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag061\/67019769\/sfag061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag061\/67019769\/sfag061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag061\/67019769\/sfag061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:11:45Z","timestamp":1776773505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag061\/8493020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag061","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,20]]},"article-number":"sfag061"}}